Astal Laboratories Share Price
78.00-1.44 (-1.81%)
-9.30% past 1 Year
Macro International Ltd is engaged in the exporting of goods as well as sales through the departmental stores. The company trades in bridles, halters, rugs, saddles, strip leather, reins, shoes
Corporate filings & documents
Announcements
Astal Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/09/2026 inter alia to consider and approve 1. To Consider & to approve the Notice of 33rd Annual General Meeting of the Company along with fixing the day date time and Venue of Annual General Meeting of the Company;2. To Approve Board Report along with all other necessary Annexure for the financial year ended March 31 2026;3. To Appoint Scrutinizer to scrutinize voting during the AGM and remote e-voting;4. Any other matter with the permission of chair.
3 days agoAstal Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/09/2026 inter alia to consider and approve 1. To Consider & to approve the Notice of 33rd Annual General Meeting of the Company along with fixing the day date time and Venue of Annual General Meeting of the Company;2. To Approve Board Report along with all other necessary Annexure for the financial year ended March 31 2026;3. To Appoint Scrutinizer to scrutinize voting during the AGM and remote e-voting;4. Any other matter with the permission of chair.
3 days agoSubmission of Newspaper publication of financial results for the quarter ended 30th June 2026.
2 weeks agoSubmission of Newspaper publication of financial results for the quarter ended 30th June 2026.
2 weeks agoSubmission of Statement of Deviation & Variation
2 weeks agoSubmission of Statement of Deviation & Variation
2 weeks agoSubmission of Financial Results for the quarter ended June 30 2026.
2 weeks agoSubmission of Financial Results for the quarter ended June 30 2026.
2 weeks agoSubmission of Outcome of Board Meeting.
2 weeks agoSubmission of Outcome of Board Meeting.
2 weeks agoAstal Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve Prior intimation of Board meeting to approve quarterly financial results for the quarter ended 30th June 2026.
3 weeks agoAstal Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve Prior intimation of Board meeting to approve quarterly financial results for the quarter ended 30th June 2026.
3 weeks agoSubmission of Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
1 month agoSubmission of Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
1 month agoSubmission of Trading Window Closure Intimation.
2 months agoSubmission of Trading Window Closure Intimation.
2 months agoOutcome of board meeting held on today i.e. 29th June 2026.
2 months agoOutcome of board meeting held on today i.e. 29th June 2026.
2 months ago<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Astal Laboratories Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L74120UP1993PLC015605</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>13.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Mahendra Kumar <br/> Designation: Company Secretary and Compliance officer <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: BALAYOGISWARA RAO PEDDINTI <br/> Designation: Chief Financial Officer <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 22/06/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
2 months ago<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Astal Laboratories Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L74120UP1993PLC015605</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>13.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Mahendra Kumar <br/> Designation: Company Secretary and Compliance officer <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: BALAYOGISWARA RAO PEDDINTI <br/> Designation: Chief Financial Officer <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 22/06/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
2 months agoNewspaper publication.
2 months agoNewspaper publication.
2 months agoSubmission of newspaper publication for financial results for the quarter and year ended March 2026.
3 months agoSubmission of newspaper publication for financial results for the quarter and year ended March 2026.
3 months agoIntimation of authorization of KMPs under regulation 30 (5) of SEBI (LODR) Regulations 2015.
3 months agoInternal Auditor appointment for the financial year 2026-27.
3 months agoFinancial Results for quarter and year ended March 31 2026
3 months agoStatement of Deviation and variation
3 months agoStatement of Deviation and variation
3 months agoAudited standalone and consolidated financial results for the quarter and financial year ended March. 31 2026.
3 months agoAudited standalone and consolidated financial results for the quarter and financial year ended March. 31 2026.
3 months agoOutcome of Board Meeting held on Saturday 30th May 2026.
3 months agoAnnual Secretarial Compliance Report for the period March 31 2026.
3 months agoAnnual Secretarial Compliance Report for the period March 31 2026.
3 months agoIntimation of Lapse and forfeiture of Convertible Warrants allotted on 27th November 2024.
3 months agoIntimation of Lapse and forfeiture of Convertible Warrants allotted on 27th November 2024.
3 months agoIntimation of Allotment of equity shares pursuant to conversion of warrants.
3 months agoIntimation of Allotment of equity shares pursuant to conversion of warrants.
3 months agoAstal Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve 1. To Consider and Approve the audited standalone and Consolidated financial results for the quarter and year ended March 31 2026 along with limited review report of the auditors.2. To consider and approve the audited standalone and consolidated financial statements of the Company for the financial year ended March 31 2026 along with report of the auditors.3. To Appoint Internal Auditor for the Financial Year 2026-27.4. Any other matter with the permission of chair.
3 months agoOutcome of Board meeting held today 25th May 2026.
3 months agoOutcome of Board meeting held today 25th May 2026.
3 months agoIntimation of appointment of statutory auditor in material wholly owned subsidiary company to fill the casual vacancy due to resignation.
3 months agoMonitoring Agency report for the quarter ended 31st March 2026.
3 months agoMonitoring Agency report for the quarter ended 31st March 2026.
3 months agoSubmission of intimation of resignation of statutory auditors of Sriven Pharmachem India Private limited a material subsidiary of the Company.
3 months agoSubmission of intimation of allotment of equity shares pursuant to conversion of warrants.
3 months agoSubmission of outcome of Board Meeting held on 12th May 2026.
3 months agoSubmission of clarification w.r.t. clarification sought by BSE.
3 months agoSubmission of clarification w.r.t. clarification sought by BSE.
3 months agoThe Exchange has sought clarification from Astal Laboratories Ltd on May 11 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.
3 months agoAnnual reports
Concalls & investor presentations
No presentations found
Corporate Actions
Date
Type
Details
No data available.
Company details
Registered office
Office No B7 A - 40, Sector 4 Gautam Buddha Nagar Noida Uttar Pradesh PIN: 201301 Tel No: NULL Fax No: NULL Email: [email protected] Internet: https://astallabs.com/
Registrars
Beetal House , 99 Mandangir,3rd Floor, Behind Local Shopping Centre,Near Dada Harsukhdas Mandir,New Delhi Beetal House , 99 Mandangir 3rd Floor, Behind Local Shopping Centre Near Dada Harsukhdas Mandir PIN: Tel No: 011-29961281 -82 Fax No: 011-29961284 Email: NULL
Management
Mahendra Kumar, Company Secretary & Compliance Officer
Sudheer Karna Kankanala, Whole Time Director
Maggidi Venkatesh, Non Executive Director
Birendrakumar Sahoo, Non Executive Independent Director
Radhakishore Pandrangi, Non Executive Independent Director
Hemachakrapani Bangaraiahgari, Non Executive Independent Director
Julius Paul Reinhard Paschke, Non Executive Independent Director
Shailaja Ravikanti, Non Executive Director
Details
BSE 512600
NSE NULL
ISIN INE307N01014